Vanda Pharmaceuticals, Inc. is once again pursuing novel litigation against the US Food and Drug Administration, this time claiming the agency shared confidential information in its new drug applications with generic competitors.
In a
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?